News & press

Ceres Pharma reached an agreement with Dovesco to acquire 100% of the shares of Labophar. Simultaneously Dovesco will re-invest its proceeds in Ceres.

Ceres Pharma, a Belgian based dynamic and fast growing pharmaceutical company, active in Women’s and Family healthcare, has come to an agreement for the acquisition of the Romanian firm Dacia Plant.

Belgian based Ceres Pharma, a dynamic and fast growing pharmaceutical company, active in healthcare & well-being, has completed the acquisition of GlobiFer Intl. The acquisition of GlobiFer Intl. fits perfectly within Ceres Pharma’s women’s health strategy and is an important step to exploit Ceres Pharma’s export potential.

Naxicap Partners acquires Ceres Pharma NV from Alychlo NV & co-founder Mario Debel who will lead this new phase of growth as CEO and shareholder

Belgian based Ceres Pharma, a dynamic and fast-growing pharmaceutical company, active in healthcare & well-being, has completed the acquisition of the Bulgarian firm, ABOPharma. The price of the takeover will not be disclosed.

Belgian owned Ceres Pharma, a dynamic and fast-growing pharmaceutical company active in healthcare & well-being, has completed the acquisition of the Romanian firm Viva Pharma. The price of the takeover will not be disclosed.

Ceres Pharma acquires exclusive license rights to a new generation of Vitamin D medicine for the Belgium and Lux market.

The pharmaceutical company Ceres Pharma from Merelbeke is acquiring the Belgian company 2Pharma.

October 2018, Ceres Pharma launches BELÈNE® ; an innovative high-quality skin care brand.

Takeover of Ceumed means Ceres Pharma from now on present in 6 countries in Central and Eastern Europe